Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Crescent Biopharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- −6 vs. Q2 2023
- Shares held
- 34.7M
- −864.9K (−2.4%) vs. Q2 2023
- Total value
- $52.1M
- −$9.84M (−15.9%) vs. Q2 2023
- New holders
- 5
- 8 more added
- Sold out
- 11
- 18 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 9,544,262 | $14.3M | 0.39% | 00.0% | Unchanged |
| Artal Group S.A. | 8,589,064 | $12.9M | 0.56% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,764,440 | $7.15M | 0.55% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 3,000,000 | $4.50M | 0.79% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,421,869 | $3.63M | 0.00% | +107,464+4.6% | Added |
| AXA S.A. | 1,625,698 | $2.44M | 0.01% | −5,811−0.4% | Reduced |
| Acadian Asset Management LLC | 844,051 | $1.26M | 0.01% | −305,605−26.6% | Reduced |
| Goldman Sachs Group Inc | 794,494 | $1.19M | 0.00% | +10,763+1.4% | Added |
| BlackRock Inc. | 734,704 | $1.10M | 0.00% | −49,201−6.3% | Reduced |
| Geode Capital Management, LLC | 459,845 | $690.0K | 0.00% | −16,395−3.4% | Reduced |
| Two Sigma Advisers, LP | 219,000 | $328.5K | 0.00% | −232,102−51.5% | Reduced |
| Renaissance Technologies LLC | 201,107 | $302.0K | 0.00% | +85,007+73.2% | Added |
| State Street Corp | 186,765 | $280.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 172,200 | $258.3K | 0.01% | +36,300+26.7% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 149,106 | $223.7K | 0.00% | −7,085−4.5% | Reduced |
| Two Sigma Investments, LP | 114,072 | $171.1K | 0.00% | −75,656−39.9% | Reduced |
| Northern Trust Corp | 106,236 | $159.4K | 0.00% | −14,637−12.1% | Reduced |
| Franklin Resources Inc | 95,893 | $143.8K | 0.00% | −24,778−20.5% | Reduced |
| Gsa Capital Partners LLP | 93,785 | $141.0K | 0.01% | +93,785 | New |
| Millennium Management LLC | 63,896 | $95.8K | 0.00% | −13,903−17.9% | Reduced |
| Intellectus Partners, LLC | 61,975 | $93.0K | 0.03% | −11,500−15.7% | Reduced |
| Sargent Investment Group, LLC | 58,000 | $87.0K | 0.02% | −50,000−46.3% | Reduced |
| Letko, Brosseau & Associates Inc | 45,250 | $67.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 44,532 | $66.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 40,385 | $60.6K | 0.00% | −57,546−58.8% | Reduced |
| Ieq Capital, LLC | 38,363 | $57.5K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 32,722 | $49.1K | 0.01% | +2,724+9.1% | Added |
| Group One Trading, L.P. | 28,401 | $42.6K | 0.00% | −25,738−47.5% | Reduced |
| Acuta Capital Partners, LLC | 27,500 | $41.3K | 0.03% | +27,500 | New |
| Bank of New York Mellon Corp | 24,875 | $37.3K | 0.00% | −234−0.9% | Reduced |
| Charles Schwab Investment Management Inc | 22,361 | $33.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,967 | $29.9K | 0.00% | +19,967 | New |
| Chicago Partners Investment Group LLC | 20,000 | $23.4K | 0.00% | 00.0% | Unchanged |
| Tobias Financial Advisors, Inc. | 15,000 | $22.5K | 0.01% | 00.0% | Unchanged |
| LPL Financial LLC | 13,000 | $19.5K | 0.00% | +3,000+30.0% | Added |
| Pine Valley Investments Ltd Liability Co | 12,520 | $18.8K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8,224 | $12.3K | 0.00% | +125+1.5% | Added |
| Tower Research Capital LLC (TRC) | 4,662 | $6.99K | 0.00% | −3,955−45.9% | Reduced |
| Hartford Financial Management Inc. | 3,500 | $5.25K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 2,057 | $3.09K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 1,044 | $1.57K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 481 | $722 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 466 | $699 | 0.00% | −323−40.9% | Reduced |
| Qube Research & Technologies Ltd | 399 | $599 | 0.00% | +399 | New |
| Wells Fargo & Company | 357 | $536 | 0.00% | −18−4.8% | Reduced |
| Barclays PLC | 152 | $228 | 0.00% | +76+100.0% | Added |
| Signaturefd, LLC | 100 | $150 | 0.00% | +100 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −142,400−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −101,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −42,069−100.0% | Sold out |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −33,340−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −18,340−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,984−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,323−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,062−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −575−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −395−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −167−100.0% | Sold out |